3
Registered trials
1
Recruiting
2
Unique sponsors
2
Unique IMPs
3
Commercial trials
Drug classes (ATC)
—
ATC code not specified
2
N
Neurology/Psychiatry (ATC N)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Phase III:
1
Phase II:
2
Phase III
1 trial-
EndedArgenx CommercialEMPASIPRUBART
Phase II
2 trials-
EndedArgenx CommercialEMPASIPRUBART
-
RecruitingDianthus Therapeutics Inc. CommercialDNTH103
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Argenx | Commercial | 2 | Phase II, Phase III | 0 |
| Dianthus Therapeutics Inc. | Commercial | 1 | Phase II | 1 |
New trials by year
2023
1
2025
2